Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Albelda

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
Annals of Surgery|September 1, 1995
The role of immunosuppression in the efficacy of cancer gene therapy using adenovirus transfer of the herpes simplex thymidine kinase geneA A Elshami, J C Kucharczuk, D H Sterman, et al.
American Journal of Respiratory Cell and Molecular Biology|July 1, 1995
Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancerH C Hwang, W R Smythe, A A Elshami, et al.
Development (Cambridge, England)|September 1, 1994
Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular developmentH S Baldwin, H M Shen, H C Yan, et al.
Cancer Research|August 17, 2001
Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunityM Odaka, D H Sterman, R Wiewrodt, et al.
Human Gene Therapy|December 1, 1996
Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primatesJ C Kucharczuk, S Raper, A A Elshami, et al.
Cancer Research|June 13, 2000
Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor modelsM Lanuti, S Rudginsky, S D Force, et al.
Human Gene Therapy|February 27, 1999
Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapyM Lanuti, G P Gao, S D Force, et al.
Human Gene Therapy|June 2, 1998
Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesotheliomaD H Sterman, J Treat, L A Litzky, et al.
Oncogene|March 21, 2012
The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesisC Zhou, S Licciulli, J L Avila, et al.
Human Gene Therapy|October 6, 1998
Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesotheliomaK L Molnar-Kimber, D H Sterman, M Chang, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Annals of Surgery|September 1, 1995
The role of immunosuppression in the efficacy of cancer gene therapy using adenovirus transfer of the herpes simplex thymidine kinase geneA A Elshami, J C Kucharczuk, D H Sterman, et al.
American Journal of Respiratory Cell and Molecular Biology|July 1, 1995
Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancerH C Hwang, W R Smythe, A A Elshami, et al.
Development (Cambridge, England)|September 1, 1994
Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular developmentH S Baldwin, H M Shen, H C Yan, et al.
Cancer Research|August 17, 2001
Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunityM Odaka, D H Sterman, R Wiewrodt, et al.
Human Gene Therapy|December 1, 1996
Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primatesJ C Kucharczuk, S Raper, A A Elshami, et al.
Cancer Research|June 13, 2000
Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor modelsM Lanuti, S Rudginsky, S D Force, et al.
Human Gene Therapy|February 27, 1999
Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapyM Lanuti, G P Gao, S D Force, et al.
Human Gene Therapy|June 2, 1998
Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesotheliomaD H Sterman, J Treat, L A Litzky, et al.
Oncogene|March 21, 2012
The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesisC Zhou, S Licciulli, J L Avila, et al.
Human Gene Therapy|October 6, 1998
Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesotheliomaK L Molnar-Kimber, D H Sterman, M Chang, et al.
Pageof 15